Not affiliated with the Pennsylvania General Assembly · an independent reference by Fifty Domes

PlansSign in

Bills › 2025–2026 Regular Session › House of Representatives bill

HB 8092025–2026
bill

2025–2026 Regular Session · House of Representatives bill

HB 809

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for prohibited acts and penalties; and providing for syringe service programs authorized.

In committee Last action March 5, 2025: Referred to Judiciary

Official bill page and text: palegis.us

Sponsors 7

Prime sponsor
James Struzzi
Cosponsors (6)
Benjamin Sanchez, Dan Frankel, G. Roni Green, Lindsay Powell, Steven Malagari, Tarik Khan

Status

In committee as of March 5, 2025. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 1

DateChamberAction
March 5, 2025HouseReferred to Judiciary

Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.

Sources for this page

Bill, action and roll-call data from Open States (public data, attribution appreciated). Neither Pennsylvania Capitol Guide nor this information, as presented here, is endorsed by the Pennsylvania General Assembly.